Thomas A Pearson

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Integration of the Case-Based Series in Population-Oriented Prevention into a problem-based medical curriculum
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York 14642, USA
    Am J Prev Med 24:102-7. 2003
  2. pmc Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort
    MICHAEL JACOB ADAMS
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Radiat Res 174:753-62. 2010
  3. pmc Training medical students in community health: a novel required fourth-year clerkship at the University of Rochester
    Scott McIntosh
    Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14627 8969, USA
    Acad Med 83:357-64. 2008
  4. ncbi request reprint A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA
    Mayo Clin Proc 80:587-95. 2005
  5. ncbi request reprint Lateral automobile impacts and the risk of traumatic brain injury
    Jeffrey J Bazarian
    Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Ann Emerg Med 44:142-52. 2004
  6. ncbi request reprint Lipoprotein(a): implications for clinical practice
    Robert C Block
    Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, NY 14627, USA
    Curr Atheroscler Rep 7:327-9. 2005
  7. ncbi request reprint The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester, Rochester, New York 14642, USA
    Am J Cardiol 94:4F-8F. 2004
  8. ncbi request reprint Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary
    Deborah R Levy
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York, USA
    J Gerontol A Biol Sci Med Sci 60:597-8; author reply 602. 2005
  9. ncbi request reprint Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease
    Deborah R Levy
    University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Clin Cardiol 28:317-20. 2005
  10. ncbi request reprint Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease
    Mark G Davies
    Center for Vascular Disease, Division of Vascular Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
    J Am Coll Surg 201:275-96. 2005

Detail Information

Publications53

  1. ncbi request reprint Integration of the Case-Based Series in Population-Oriented Prevention into a problem-based medical curriculum
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York 14642, USA
    Am J Prev Med 24:102-7. 2003
    ..Issues of implementation and evaluation of the C-POP curriculum are discussed...
  2. pmc Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort
    MICHAEL JACOB ADAMS
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Radiat Res 174:753-62. 2010
    ..5 years of follow-up and is dose-dependent. Although the incidence appeared to decrease after 40 years, increased risk remains a lifelong concern in those exposed to lower doses of medical radiation during early childhood...
  3. pmc Training medical students in community health: a novel required fourth-year clerkship at the University of Rochester
    Scott McIntosh
    Department of Community and Preventive Medicine, University of Rochester, Rochester, NY 14627 8969, USA
    Acad Med 83:357-64. 2008
    ..Evaluation efforts to date indicate that the clerkship has been received favorably by both faculty and students...
  4. ncbi request reprint A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA
    Mayo Clin Proc 80:587-95. 2005
    ....
  5. ncbi request reprint Lateral automobile impacts and the risk of traumatic brain injury
    Jeffrey J Bazarian
    Department of Emergency Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Ann Emerg Med 44:142-52. 2004
    ..We determine the relative risk and severity of traumatic brain injury among occupants of lateral impacts compared with occupants of nonlateral impacts...
  6. ncbi request reprint Lipoprotein(a): implications for clinical practice
    Robert C Block
    Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, NY 14627, USA
    Curr Atheroscler Rep 7:327-9. 2005
  7. ncbi request reprint The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester, Rochester, New York 14642, USA
    Am J Cardiol 94:4F-8F. 2004
    ..Risk reduction in this group, which contributes a significant portion of CAD cases, should be part of any program to reduce the population burden of CAD...
  8. ncbi request reprint Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary
    Deborah R Levy
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York, USA
    J Gerontol A Biol Sci Med Sci 60:597-8; author reply 602. 2005
  9. ncbi request reprint Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease
    Deborah R Levy
    University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    Clin Cardiol 28:317-20. 2005
    ..2 mmol/I (< 200 mg/dl). Combination therapy offers a means to get more people to goal. This paper reviews the impact of lipid-modifying combination therapy with niacin plus a statin on lipid profile outcomes...
  10. ncbi request reprint Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease
    Mark G Davies
    Center for Vascular Disease, Division of Vascular Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
    J Am Coll Surg 201:275-96. 2005
  11. ncbi request reprint Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: a substudy of the Ezetimibe add-on to statin for effectiveness t
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, NY 14642, USA
    Mayo Clin Proc 81:1177-85. 2006
    ....
  12. ncbi request reprint Education and income: double-edged swords in the epidemiologic transition of cardiovascular disease
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
    Ethn Dis 13:S158-63. 2003
    ..The goal of improved education and eradication of poverty in Africa should not and need not carry the unhappy consequence of a cardiovascular disease epidemic...
  13. ncbi request reprint Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial
    Ronald G Schwartz
    Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    J Am Coll Cardiol 42:600-10. 2003
    ....
  14. pmc Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents
    Marc B Lande
    Department of Pediatrics, University of Rochester Medical Center, 601 Elmwood Ave, Box 777, Rochester, NY 14642, USA
    Pediatrics 122:1252-7. 2008
    ..The objective of this study was to determine, with a nationally representative sample of children, whether the relationship between elevated blood pressure and C-reactive protein levels may be evident before adulthood...
  15. ncbi request reprint The prevention of cardiovascular disease: have we really made progress?
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, New York, USA
    Health Aff (Millwood) 26:49-60. 2007
    ..Policy options that involve multiple preventive approaches offer the best opportunity to minimize the economic and social burdens of CVD...
  16. doi request reprint Heightened risk of cardiovascular disease in patients with rheumatoid arthritis, heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Introduction
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Am J Med 121:S1-2. 2008
  17. doi request reprint Translation of evidence-based guidelines in preventive cardiology: the EUROACTION program
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester School of Medicine, Rochester, NY 14642, USA
    Nat Clin Pract Cardiovasc Med 6:8-9. 2009
    ..The EUROACTION program is an example of effectiveness research, which aims to develop and validate strategies to implement interventions previously shown to be efficacious...
  18. doi request reprint Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy
    Thomas A Pearson
    University of Rochester School of Medicine and Dentistry, Rochester, NY, USA
    Am J Cardiol 103:369-74. 2009
    ..The effects of ezetimibe monotherapy are not well defined. The effects of ezetimibe on CRP were consistent across patient subgroups...
  19. pmc Deaf sign language users, health inequities, and public health: opportunity for social justice
    Steven Barnett
    Family Medicine Research Programs, 1381 South Ave, Rochester, NY 14620 E mail Dr Barnett is also affiliated with the Rochester Prevention Research Center, National Center for Deaf Health Research the University of Rochester Department of Family Medicine and the University of Rochester Department of Community and Preventive Medicine, Rochester, New York
    Prev Chronic Dis 8:A45. 2011
    ..We describe 4 issues that underlie health inequities experienced by deaf sign language users and propose 6 public health approaches to address these health and health care inequities to promote health and prevent chronic diseases...
  20. ncbi request reprint New tools for coronary risk assessment: what are their advantages and limitations?
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA
    Circulation 105:886-92. 2002
    ..Systemic therapy for risk reduction in primary prevention may be preferable to local therapy (eg, angioplasty and bypass) and may more effectively prevent acute coronary events than these more invasive approaches...
  21. pmc An epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007
    Robert C Block
    Department of Community and Preventive Medicine, University of Rochester, Box 644, Rochester, NY 14642, USA
    Prev Chronic Dis 9:E90. 2012
    ..Our objective was to examine the pattern of lifestyle factors associated with cardiovascular disease (CVD) in Grenada and to determine whether the prevalence of CVD risk factors differs by subgroups...
  22. ncbi request reprint Where do we go from here?
    Thomas A Pearson
    Department of Community and Preventive Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Am J Med 121:S32-4. 2008
  23. pmc Carotid endarterectomy and carotid artery stenting utilization trends over time
    Matthew R Skerritt
    Department of Community and Preventive Medicine, Rochester, NY, USA
    BMC Neurol 12:17. 2012
    ....
  24. pmc Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today
    M Jacob Adams
    University of Rochester School of Medicine and Dentistry, Department of Community and Preventive Medicine, 601 Elmwood Avenue, Box 644, Rochester, New York, USA
    Cancer Epidemiol Biomarkers Prev 19:48-58. 2010
    ....
  25. pmc Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years
    Anne N Nafziger
    Epidemiology and Public Health Sciences, Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden
    BMC Public Health 7:108. 2007
    ..The aim of this study is to characterize who is not gaining weight during a 10 year period in Sweden...
  26. ncbi request reprint Metabolic syndrome components in african-americans and European-american patients and its relation to coronary artery disease
    Erdembileg Anuurad
    Department of Medicine, University of California Davis, Davis, California, USA
    Am J Cardiol 100:830-4. 2007
    ..Although our findings may not be directly extrapolated to the population at large, they illustrate the importance of a high-risk metabolic environment as a cardiovascular risk factor...
  27. ncbi request reprint Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysis
    Donald A Berry
    University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
    Am Heart J 145:1036-45. 2003
    ..One of these studies included 2 doses of atorvastatin, and substantial additional information is available in the literature about the effect of atorvastatin on LDL-C level lowering...
  28. ncbi request reprint American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Pre
    Thomas A Pearson
    Circulation 107:645-51. 2003
  29. ncbi request reprint Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease
    Soma S Nag
    Outcomes Research and Management, Merck and Co, Inc, West Point, Pennsylvania, USA
    Am J Cardiol 95:862-4. 2005
    ..The overall lipid-lowering therapy treatment rate was 38% and the estimated lipid treatment gap (percent needing treatment who were not receiving it) was 62%...
  30. ncbi request reprint Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
    Thomas A Pearson
    Circulation 107:499-511. 2003
  31. ncbi request reprint AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Scien
    Thomas A Pearson
    Circulation 106:388-91. 2002
  32. ncbi request reprint Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity
    Guijing Lu
    Department of Medicine, University of California Davis, USA, and Department of Medicine, Xiangya Hospital of Xiangya Medical School, Central South University, Changsha, P R China
    Transl Res 149:317-23. 2007
    ..05). The results indicate that, across gender and ethnicity, low adiponectin levels may be an independent risk factor for CAD...
  33. ncbi request reprint Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol
    Erdembileg Anuurad
    Department of Medicine, University of California, Davis, CA, USA
    J Lipid Res 47:2475-81. 2006
    ....
  34. ncbi request reprint CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group
    Stephen P Fortmann
    Circulation 110:e554-9. 2004
    ..Although considerable work has been published since this review was completed, the perspectives and issues presented are still useful in evaluating the use of inflammation markers for risk stratisfication and prevention...
  35. ncbi request reprint Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum
    Sidney C Smith
    Center for Cardiovascular Science and Medicine, University of North Carolina School of Medicine, Chapel Hill 27599 7075, USA
    Circulation 109:3112-21. 2004
  36. ncbi request reprint CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview
    Thomas A Pearson
    Circulation 110:e543-4. 2004
  37. ncbi request reprint Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations
    Michael H Davidson
    Radiant Development, Chicago, Illinois, USA
    Am J Cardiol 96:556-63. 2005
    ..Most of those (75%) with cardiovascular disease in NEPTUNE II would be considered very high risk and candidates for aggressive therapy to reach the new optional treatment goals...
  38. ncbi request reprint Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report
    Lori Mosca
    Circulation 106:e167-72. 2002
  39. ncbi request reprint Positioning technology to serve global heart health: the Fifth International Heart Health Conference
    Thomas A Pearson
    Eur J Cardiovasc Prev Rehabil 11:265-6. 2004
  40. ncbi request reprint A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am Heart J 150:401. 2005
    ..We sought to characterize the risk factors and treatments of a diverse contemporary population of patients with atherothrombosis...
  41. ncbi request reprint Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology
    Barbara V Howard
    Circulation 105:e132-7. 2002
  42. ncbi request reprint B vitamins and restenosis after coronary angioplasty
    Doru V Chirieac
    N Engl J Med 346:1093-5. 2002
  43. ncbi request reprint Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices
    Mary N Walsh
    Northside Cardiology, Indianapolis, Ind, USA
    Am J Manag Care 8:937-46. 2002
    ..To observe the experience of 9 practice sites in implementing provider-defined disease management programs for coronary heart disease patients...
  44. ncbi request reprint Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Deepak L Bhatt
    Cleveland Clinic, Cleveland, USA
    N Engl J Med 354:1706-17. 2006
    ..Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events...
  45. ncbi request reprint Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial
    Deepak L Bhatt
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Am Coll Cardiol 49:1982-8. 2007
    ..The purpose of this study was to determine the possible benefit of dual antiplatelet therapy in patients with prior myocardial infarction (MI), ischemic stroke, or symptomatic peripheral arterial disease (PAD)...
  46. ncbi request reprint ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study
    Erdembileg Anuurad
    Department of Medicine, University of California, Davis, CA, USA
    J Lipid Res 48:693-8. 2007
    ..For large apo[a] sizes, apoE genotype contributed to the observed African American-Caucasian differences in allele-specific apo[a] levels...
  47. ncbi request reprint Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women
    Christine L Pelkman
    Department of Exercise and Nutrition Sciences, The State University of New York at Buffalo, NY, USA
    Am J Clin Nutr 79:204-12. 2004
    ..Previous studies in weight-stable persons showed that a moderate-fat diet results in a more favorable lipid and lipoprotein profile (ie, lower serum triacylglycerol and higher HDL cholesterol) than does a low-fat diet...
  48. ncbi request reprint An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial
    Thomas H Wang
    Cleveland Clinic, Cleveland, OH, USA
    Eur Heart J 28:2200-7. 2007
    ..aspirin alone in the prespecified 'asymptomatic' subgroup of CHARISMA, we investigated whether dual-antiplatelet therapy may be associated with adverse cardiovascular (CV) events in a primary prevention population...
  49. ncbi request reprint In the clinic. Dyslipidemia
    Laurie A Kopin
    Ann Intern Med 147:ITC9-1-ITC9-16. 2007
  50. pmc Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up
    Dhananjay Vaidya
    Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Am J Cardiol 100:1410-5. 2007
    ..In conclusion, in families with a history of premature CAD, the excess risk observed cannot be attributed to traditional risk factors, suggesting a major role for as yet undetermined genetic and other susceptibility factors...
  51. pmc Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II
    Luther T Clark
    State University of New York Downstate Medical Center, Brooklyn, NY, USA
    J Gen Intern Med 21:320-6. 2006
    ..Data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey were used to assess ethnic differences in low-density lipoprotein cholesterol (LDL-C) goal achievement...
  52. pmc High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans
    Erdembileg Anuurad
    Department of Medicine, University of California, Davis, Sacramento, California 95817, USA
    J Clin Endocrinol Metab 93:1482-8. 2008
    ..Lipoprotein(a) [Lp(a)] is an independent CVD risk factor where plasma levels are determined by the apolipoprotein(a) [apo(a)] gene, which contains inflammatory response elements...
  53. ncbi request reprint Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states
    Lars Berglund
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Am J Clin Nutr 86:1611-20. 2007
    ..In subjects with a high prevalence of metabolic risk abnormalities, the preferred replacement for saturated fat is unresolved...